Navigation Links
Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
Date:2/22/2013

NEW YORK, Feb. 22, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur , the Company's Chief Executive Officer, will be presenting at the Citigroup 2013 Global Healthcare Conference, being held February 25-27, 2013, in New York City.  Mr. Bentsur's presentation is scheduled to take place on Wednesday, February 27th, at 2:15 PM ET. 

A live audio webcast of Mr. Bentsur's presentation will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease. Keryx is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex has completed a U.S.-based Phase 3 clinical program for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, conducted pursuant to a Special Protocol Assessment (SPA) agreement with the FDA, and Keryx expects to submit an NDA with the FDA and a MAA with the EMA in the second quarter of 2013.  Zerenex is also in Phase 2 development in the U.S. for the management of phosphorus and iron deficiency in anemic patients with Stage 3 to 5 non-dialysis dependent chronic kidney disease.  In addition, Keryx's Japanese partner, Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. has filed its New Drug Application for marketing approval of ferric citrate in <
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
2. Keryx Biopharmaceuticals Announces $55 Million Proposed Public Offering of Common Stock
3. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Third Quarter 2012 Financial Results
4. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
5. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
6. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
7. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
8. Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
9. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
10. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
11. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... This report analyzes the worldwide markets for ADME-Toxicology ... (In-Vivo, & In-Vitro), and ADME Testing. The report provides separate ... Japan , Europe , ... estimates and forecasts are provided for the period 2014 through ... markets. Market data and analytics are derived from primary and ...
(Date:4/20/2015)... 20, 2015 This report analyzes the worldwide ... Million. The report provides separate comprehensive analytics for the ... , and Rest of World. Annual estimates and ... Also, a seven-year historic analysis is provided for these ... and secondary research. Company profiles are primarily based on ...
(Date:4/20/2015)...  Johnson & Johnson (NYSE: JNJ ) will ... investment community beginning at 8:30 a.m. (Eastern Time) on ... in New Brunswick, New Jersey ... Paul Stoffels , M.D., Worldwide Chairman Pharmaceuticals, and Chief ... Pharmaceuticals will host the meeting. Dominic Caruso , ...
Breaking Medicine Technology:World ADME-Toxicology Testing Industry 2World ADME-Toxicology Testing Industry 3World ADME-Toxicology Testing Industry 4World ADME-Toxicology Testing Industry 5World ADME-Toxicology Testing Industry 6World ADME-Toxicology Testing Industry 7World ADME-Toxicology Testing Industry 8World ADME-Toxicology Testing Industry 9World ADME-Toxicology Testing Industry 10World ADME-Toxicology Testing Industry 11World ADME-Toxicology Testing Industry 12World ADME-Toxicology Testing Industry 13World ADME-Toxicology Testing Industry 14World ADME-Toxicology Testing Industry 15World ADME-Toxicology Testing Industry 16World ADME-Toxicology Testing Industry 17World ADME-Toxicology Testing Industry 18World ADME-Toxicology Testing Industry 19World Medical Equipment Rental and Leasing Industry 2World Medical Equipment Rental and Leasing Industry 3World Medical Equipment Rental and Leasing Industry 4World Medical Equipment Rental and Leasing Industry 5World Medical Equipment Rental and Leasing Industry 6World Medical Equipment Rental and Leasing Industry 7
(Date:4/20/2015)... April 20, 2015 Florida Hospital at ... three prestigious awards from Select Medical, during the annual ... Friday, April 10th. Chief Operating Officer, Debi Martoccio, received ... She was one of six recipients out of 113 ... Dinney Humanitarian Award for the contributions to the community ...
(Date:4/20/2015)... 20, 2015 “ Verus ” was ... Report, which features the latest and coolest technology products ... special reporter for NewsWatch, conducted the review and shared ... variety of purposes. , According to CNET, at least ... in 2013. It’s unfortunate that smartphones break so easily, ...
(Date:4/20/2015)... Hill, FL (PRWEB) April 20, 2015 ... health issue in the United States for decades. ... lost productivity, healthcare costs and property damage each year, ... its victims, as well as their families and loved ... Suncoast Rehabilitation Center is dedicated to raising awareness ...
(Date:4/20/2015)... Plainsboro, NJ (PRWEB) April 20, 2015 ... Centers of America and editor-in-chief of OncologyLive magazine ... women with BRCA-mutated advanced ovarian cancer is too restrictive ... In an interview featured on OncLive.com, Maurie Markman, M.D., ... high-grade serous ovarian cancer who do not test positive ...
(Date:4/20/2015)... Catalent, the leading global provider ... drugs, biologics and consumer health products, today announced ... as part of a consortium looking to evaluate, ... nano-pharmaceutical virosome-based vaccine candidates. , Currently, 90% of ... of the consortium is to develop a scalable ...
Breaking Medicine News(10 mins):Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 2Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 3Health News:Attractive and Durable Phone Cases were Featured on NewsWatch Television 2Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 2Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 3Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 4Health News:Recent FDA Approval of Ovarian Cancer Treatment Is Too Restrictive, Specialist in Gynecologic Malignancies Says in OncLive® Article 2Health News:Catalent Awarded Grant as Part of Vaccine Research Consortium 2Health News:Catalent Awarded Grant as Part of Vaccine Research Consortium 3Health News:Catalent Awarded Grant as Part of Vaccine Research Consortium 4Health News:Catalent Awarded Grant as Part of Vaccine Research Consortium 5
... prostate cancer was extremely dangerous, men over 75, may ... prostatectomy or radiation does help to eradicate ... is often affected because of resulting urinary incontinence and ... Hoffman, an associate professor of medicine at the University ...
... relief to the anti-quota camp, the Supreme Court Friday ... 10 percent seats on an all-India basis// for scheduled ... for the 2006-07 academic year. ,A bench of ... the submissions of Additional Solicitor General Gopal Subramaniam that ...
... The official death toll that has been reported in Angola ... unusually high mortality rate and it is expected to affect ... ,Since the first report of the outbreak in ... been reported. ,Uige, a city 300km northeast of ...
... distinction of accounting for 25 percent of global maternal ... to promote safe motherhood. // ,The Federation ... marked the successful conclusion of its first such effort ... by gynaecologist Shirin Venkat along the Ganges. ...
... to house some of Europe’s biggest Poultry farms, has been ... H7N3 Strain of bird flu on three of its farms. ... culling of birds, and have ensured its safe disposal, cleansing ... have issued this statement., ,A restricted zone extending nearly ...
... a Nobel laureate hopes to manufacture plentiful anti-flu drugs at ... Corey has work out the method while relaxing at home ... the drug and given it to World Health Organization to ... (shikimic acid) for the production cycle is a compound extracted ...
Cached Medicine News:Health News:Supreme Court Quashed Reservation Quotas For PG Medical Courses 2Health News:Death from Cholera Rises in Angola 2Health News:Doctors Join Hands To Spread Awareness Against Maternal Mortality 2
Indirect hemagglutination test for the qualitative and quantitative determination of antibodies to Toxoplasma gondii in serum....
Latex agglutination slide test for the qualitative and semi-qualitative detection of antinuclear antibodies to aid in the diagnosis of systemic lupus erthyematosus....
Color-enhanced slide test for the rapid qualitative and semi-quantitative detection of antibodies to streptococcal extracellular antigens in serum, plasma and peripheral blood....
Latex agglutination slide test to aid in the identification of Staphylococcus aureus colonies from culture media....
Medicine Products: